CLINICAL_TRIALS
trial_result
· 2018-11-09
Clinical Trial Update: Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus [Phase 1]
Summary
Phase I study of belimumab in Chinese subjects with systemic lupus erythematosus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED | Results posted: 2018-11-09